中国医药指南
中國醫藥指南
중국의약지남
CHINA MEDICINE GUIDE
2014年
32期
32-32,34
,共2页
益气复脉注射液%缺血性心肌病%心力衰竭
益氣複脈註射液%缺血性心肌病%心力衰竭
익기복맥주사액%결혈성심기병%심력쇠갈
Yiqi Fumai Injection%Ischemic cardiomyopathy%Heart failure
目的:评价益气复脉注射液治疗缺血性心肌病心力衰竭患者临床疗效。方法将入选56例缺血性心肌病心力衰竭患者随机分为常规治疗组和应用益气复脉注射液组,益气复脉组在常规组治疗基础上给予静脉滴注益气复脉2.6g溶于5%葡萄糖液250mL,每天1次,连续应用2周。观察治疗前后NYHA心功能分级、NT-proBNP值、左室射血分数(LVEF)变化。结果治疗前后两组别患者临床主要症状体征均明显好转,治疗组胸闷、气短、活动耐力改善较对照组更明显。NYHA心功能分级比较:两组患者治疗后NYHA心功能分级均显著改善。结论常规西药治疗基础上加用中药益气复脉注射液,可显著改善缺血性心肌病心力衰竭患者的临床症状。
目的:評價益氣複脈註射液治療缺血性心肌病心力衰竭患者臨床療效。方法將入選56例缺血性心肌病心力衰竭患者隨機分為常規治療組和應用益氣複脈註射液組,益氣複脈組在常規組治療基礎上給予靜脈滴註益氣複脈2.6g溶于5%葡萄糖液250mL,每天1次,連續應用2週。觀察治療前後NYHA心功能分級、NT-proBNP值、左室射血分數(LVEF)變化。結果治療前後兩組彆患者臨床主要癥狀體徵均明顯好轉,治療組胸悶、氣短、活動耐力改善較對照組更明顯。NYHA心功能分級比較:兩組患者治療後NYHA心功能分級均顯著改善。結論常規西藥治療基礎上加用中藥益氣複脈註射液,可顯著改善缺血性心肌病心力衰竭患者的臨床癥狀。
목적:평개익기복맥주사액치료결혈성심기병심력쇠갈환자림상료효。방법장입선56례결혈성심기병심력쇠갈환자수궤분위상규치료조화응용익기복맥주사액조,익기복맥조재상규조치료기출상급여정맥적주익기복맥2.6g용우5%포도당액250mL,매천1차,련속응용2주。관찰치료전후NYHA심공능분급、NT-proBNP치、좌실사혈분수(LVEF)변화。결과치료전후량조별환자림상주요증상체정균명현호전,치료조흉민、기단、활동내력개선교대조조경명현。NYHA심공능분급비교:량조환자치료후NYHA심공능분급균현저개선。결론상규서약치료기출상가용중약익기복맥주사액,가현저개선결혈성심기병심력쇠갈환자적림상증상。
Objective?To?evaluate?clinical?effects?of?Yiqi?Fumai?Injection?on?heart?failure?patients?with?ischemic?cardiomyopathy.?Methods?56?patients?were?randomly?divided?into?two?groups:?control?group?and?Yiqi?Fumai?group.?In?Yiqi?Fumai?group,we?gave?corresponding?treatment(5%GS250ml+Yiqi?Fumai2.6g,per?a?day,for?two?weeks),the?last?treatment?the?same?as?control?group.?Then,?we?observed?differences?0f?two?groups?in?NYHA,?NT-proBN,?LVEF.?Result?Before?and?after?treatment?in?two?groups?of?patients?with?clinical?main?symptoms?and?signs?were?improved?in?the?treatment?group?of?chest?tightness,?shortness of breath, activity tolerance improvement is better than the control group. NYHA classiifcation of cardiac function were compared between the two groups after treatment in patients with NYHA classiifcation of cardiac function was improved. Conclusion?Our?results?suggest?that?Yiqi?Fumai?Injection?can?improve?the?clinical?symptoms?of?heart?failure?patients?with?ischemic?cardiomyopathy.